|
DDI-2010
13th
International Conference on Drug-Drug Interactions:
Critical Review of Current Scientific
Concepts and Practices in DDI Evaluation – Enzyme Inhibition, Enzyme
Induction, Transporters, and Biologics
June 15-16, 2010
Pre-conference Workshop: Practical DDI - June 14, 2010
Red Lion Hotel on Fifth, Seattle, WA,
USA
DDI-2010
is a yearly event providing a comprehensive update on the status of the
science of drug-drug interactions and its relevance to drug development.
Presentations will be given by experts from industry and academia.
Topics covered will include literature and NDA reviews, mechanism and in
vitro-in vivo extrapolation of DDI via enzyme and transporter inhibition
and induction. The conference will also include a review on the
current status of DDI potential of biologics.
|
ETS-2010
8th
International Conference on Early Toxicity Screening:
Early Elimination of NCE with Hepatotoxicity and Idiosyncratic Toxicity:
Scientific Concepts, Challenges and Novel Technologies
June 17-18, 2010
Red Lion Hotel on Fifth Avenue;
Seattle, WA, USA
ETS-2010 is a
bi-yearly event with emphasis on promising approaches and challenges in
the accurate prediction of adverse drug effects during drug development.
This year’s theme will be mechanism-based evaluation of adverse drug
effects, with academic and industrial experts presenting data from in
vitro, animal, and clinical studies. Topics covered will include risk
factors observed in the clinic and preclinical animal species, mechanisms
and mechanism-based evaluation of hepatotoxicity, as well as novel in
vitro, in silico, and in vivo technologies for the accurate assessment of
human adverse drug effects.
|